Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 164 INDUSTRY 90 NIH 33 NETWORK 13 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 2 Sarcoma, Kaposi 1 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Lymphoma 1 HIV Infections 1 Congenital Abnormalities 1 Castleman Disease 1

Interventions

fasudil 1 durvalumab 1 Sevoflurane 1 Rituximab 1 Radiotherapy 1 Propofol 1 Nivolumab 1 Massage 1 Ketamine 1 Fluorescence Polarization Immunoassay 1 Exercise 1 Echocardiography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, Follicular × Rituximab × Clear all

NCT03245021 2024-07-30

1stFLOR

Austin Health

Phase 1 Active not recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡